Advertisement

Supportive Care in Cancer

, Volume 20, Issue 6, pp 1327–1332 | Cite as

Recurrent brain tumour: the impact of illness on patient's life

  • Elena LampertiEmail author
  • Giuseppe Pantaleo
  • Claudia Yvonne Finocchiaro
  • Antonio Silvani
  • Andrea Botturi
  • Paola Gaviani
  • Lucio Sarno
  • Andrea Salmaggi
Original Article

Abstract

Purpose

Despite advances in therapies that offer improved survival rates, clinical course of brain tumours leads to a progressive functional deterioration in patients with modifications in their psychological reaction to the disease. Patients with brain tumours are rarely assessed for quality of life and psychological variables, and even fewer studies have assessed patients who have experienced a recurrence of brain tumours. Therefore, the aim of the present study is to investigate the patients with recurrent brain tumours and their reaction to the illness.

Method

We enrolled 81 patients with recurrent CNS tumours. Karnofsky Performance Status scale (KPS) was used to evaluate functional status of patients; the multidimensional aspect of quality of life was assessed through “Functional Assessment of Cancer Therapy-Brain” (FACT-Br), “Hospital Anxiety and Depression Scale” and “Psychological Distress Inventory”. These were all used as tests of psychological well-being.

Results

Distress and almost all mean FACT-Br subscale scores seemed to be significantly lower in patients, in comparison with normative data. Surprisingly, the emotional well-being mean score was significantly higher in our recurrence sample than in patients with brain tumours at first diagnosis. Anxiety seemed not to be influenced by a relapse diagnosis; instead, depression was higher and differed significantly from normative data. Low correlation between KPS and FACT-Br total and some sub-scores was found.

Conclusions

Apparent dissociation between patients' judgment on their quality of life (bad except for emotional) and their reported distress (low) is the most intriguing finding, suggesting highly preserved coping strategies in the emotional sphere, despite intact judgment and disease awareness.

Keywords

Recurrent brain tumour Quality of life Distress Depression 

Notes

Conflict of interest statement

The authors are free of professional areas of conflict of interest such as financial remuneration as employee, consultant or subcontractor with companies. The authors certify that this work was not previously sent to other journals

References

  1. 1.
    Associazione Italiana Registri tumori (2006) Incidence and mortality data of the Cancer Registries, 1998–2002. Brain Cancer. e&p http://www.registri-tumori.it/incidenza1998-2002/rapporto/Schede%20specifiche%20per%20tumore/Tumore%20del%20cervello.pdf
  2. 2.
    Zulch KJ (1986) Brain tumors. Their biology and pathology, 3rd edn. Springer Verlag, BerlinGoogle Scholar
  3. 3.
    Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:1375–1382PubMedCrossRefGoogle Scholar
  4. 4.
    Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585–2597PubMedCrossRefGoogle Scholar
  5. 5.
    Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG, Brain Cancer Register of the Fondazione IRCCS (Istituto Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 10:79–87PubMedCrossRefGoogle Scholar
  6. 6.
    Schiffer D (1993) Brain tumors: pathology and its biological correlates. Springer-Verlag, BerlinGoogle Scholar
  7. 7.
    Mork SJ, Lindegaard KF, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R, Harvei S, Ganz J (1985) Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg 63:881–889PubMedCrossRefGoogle Scholar
  8. 8.
    Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252–260PubMedCrossRefGoogle Scholar
  9. 9.
    Salander P, Bergenheim T, Henriksson R (1996) The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med 42:985–996PubMedCrossRefGoogle Scholar
  10. 10.
    Gupta T, Sarin R (2002) Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol 3:557–564PubMedCrossRefGoogle Scholar
  11. 11.
    Giovagnoli AR, Tamburini M, Boiardi A (1996) Quality of life in brain tumor patients. J Neurooncol 30:71–80PubMedCrossRefGoogle Scholar
  12. 12.
    Kleihues P, Cavenee WK (2000) World Health Organization classification of tumors, pathology and genetics of tumors of the nervous system. IARC press, LyonGoogle Scholar
  13. 13.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRefGoogle Scholar
  14. 14.
    Meyers CA, Wefel JS (2003) The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558PubMedCrossRefGoogle Scholar
  15. 15.
    Conill C, Verger E, Salamero M (1990) Performance status assessment in cancer patients. Cancer 65:1864–1866PubMedCrossRefGoogle Scholar
  16. 16.
    Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer in evaluation of chemotherapeutic agents. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205, or pp. 196Google Scholar
  17. 17.
    Sachsenheimer W, Piotrowski W, Bimmler T (1992) Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. J Neurooncol 13:177–181PubMedCrossRefGoogle Scholar
  18. 18.
    Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151–1161PubMedCrossRefGoogle Scholar
  19. 19.
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMedGoogle Scholar
  20. 20.
    Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer 7:121–127PubMedCrossRefGoogle Scholar
  21. 21.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRefGoogle Scholar
  22. 22.
    Hopwood P, Howell A, Maguire P (1991) Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 64:353–356PubMedCrossRefGoogle Scholar
  23. 23.
    Morasso G, Costantini M, Baracco G, Borreani C, Capelli M (1996) Assessing psychological distress in cancer patients: validation of a self-administered questionnaire. Oncology 53:295–302PubMedCrossRefGoogle Scholar
  24. 24.
    Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B (2004) Normative data for functional assessment of cancer therapy—general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 43:153–160PubMedCrossRefGoogle Scholar
  25. 25.
    Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40:429–434PubMedCrossRefGoogle Scholar
  26. 26.
    Fox S (2004) Preliminary psychometric testing of the Fox Simple Quality-of-Life Scale. J Neurosci Nurs 36:157–166PubMedCrossRefGoogle Scholar
  27. 27.
    Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41–49PubMedCrossRefGoogle Scholar
  28. 28.
    Fox SW, Lyon D, Farace E (2007) Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 39:61–67PubMedCrossRefGoogle Scholar
  29. 29.
    Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr, Glioma Outcomes Project Investigators (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54:358–66, discussion 366–7PubMedCrossRefGoogle Scholar
  30. 30.
    Salander P, Bergenheim AT, Hamberg K, Henriksson R (1999) Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. Fam Pract 16:143–148PubMedCrossRefGoogle Scholar
  31. 31.
    Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13:46–51PubMedCrossRefGoogle Scholar
  32. 32.
    Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2005) Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 103:841–847PubMedCrossRefGoogle Scholar
  33. 33.
    de Figueiredo JM (1993) Depression and demoralization: phenomenologic differences and research perspectives. Compr Psychiatry 34:308–311PubMedCrossRefGoogle Scholar
  34. 34.
    Pace A, Pompili A (2005) Depression in patients with high-grade glioma: results of the Glioma Project. Neurosurgery 56:E629PubMedCrossRefGoogle Scholar
  35. 35.
    Kilbride L, Smith G, Grant R (2007) The frequency and cause of anxiety and depression amongst patients with malignant brain tumours between surgery and radiotherapy. J Neurooncol 84:297–304PubMedCrossRefGoogle Scholar
  36. 36.
    Aben I, Verhey F, Lousberg R, Lodder J, Honig A (2002) Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as screening instruments for depression in stroke patients. Psychosomatics 43:386–393PubMedCrossRefGoogle Scholar
  37. 37.
    Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24:1305–1309PubMedCrossRefGoogle Scholar
  38. 38.
    Huang ME, Wartella JE, Kreutzer JS (2001) Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch Phys Med Rehabil 82:1540–1546PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Elena Lamperti
    • 1
    Email author
  • Giuseppe Pantaleo
    • 2
  • Claudia Yvonne Finocchiaro
    • 1
    • 2
  • Antonio Silvani
    • 1
  • Andrea Botturi
    • 1
  • Paola Gaviani
    • 1
  • Lucio Sarno
    • 2
  • Andrea Salmaggi
    • 1
  1. 1.Department of NeurooncologyFondazione IRCCS Istituto Neurologico C. BestaMilanItaly
  2. 2.Vita-Salute San Raffaele UniversityMilanItaly

Personalised recommendations